We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

157 hedge funds and large institutions have $403M invested in Anika Therapeutics in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 75 increasing their positions, 34 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 34

3.92% more ownership

Funds ownership: 89.83% → 93.75% (+3.9%)

3% less funds holding

Funds holding: 162 → 157 (-5)

6% less capital invested

Capital invested by funds: $429M → $403M (-$25.6M)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

43% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $11.6M

Holders
157
Holders Change
-5
Holders Change %
-3.09%
% of All Funds
3.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
75
Reduced
34
Closed
22
Calls
$6.65M
Puts
$11.6M
Net Calls
-$4.99M
Net Calls Change
-$4.69M

Top Buyers

1
Ameriprise
Ameriprise
Minnesota
+$15M
2
State Street
State Street
Massachusetts
+$7.72M
3
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management
California
+$5.98M
4
Baird Financial Group
Baird Financial Group
Wisconsin
+$5.44M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.14M

Top Sellers

1
First Manhattan
First Manhattan
New York
-$13.8M
2
EC
Engaged Capital
California
-$12.6M
3
AAM
AMI Asset Management
California
-$10.8M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.5M
5
PCM
Portolan Capital Management
Massachusetts
-$3.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$3.3M +$1.29M +37,662 +53%
JG
27
Jefferies Group
New York
$2.75M +$3.11M +90,945 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$2.54M +$740K +21,600 +35%
Charles Schwab
29
Charles Schwab
California
$2.45M +$122K +3,552 +5%
SDIC
30
South Dakota Investment Council
South Dakota
$2.41M +$185K +5,400 +7%
Goldman Sachs
31
Goldman Sachs
New York
$2.34M +$19.5K +569 +0.7%
Barrow, Hanley, Mewhinney & Strauss
32
Barrow, Hanley, Mewhinney & Strauss
Texas
$2.12M -$74.7K -2,180 -3%
Fisher Asset Management
33
Fisher Asset Management
Washington
$2.09M -$172K -5,021 -7%
Prudential Financial
34
Prudential Financial
New Jersey
$1.97M +$1.42M +41,418 +175%
OAM
35
Oxford Asset Management
United Kingdom
$1.86M -$725K -21,172 -26%
Arrowstreet Capital
36
Arrowstreet Capital
Massachusetts
$1.8M +$2.04M +59,563 New
TSW
37
Thompson Siegel & Walmsley
Virginia
$1.78M +$132K +3,840 +7%
Natixis Advisors
38
Natixis Advisors
Massachusetts
$1.7M -$2.35M -68,658 -55%
Marshall Wace
39
Marshall Wace
United Kingdom
$1.69M -$2.68M -78,323 -58%
FP
40
Foundry Partners
Minnesota
$1.68M +$1.71K +50 +0.1%
Stifel Financial
41
Stifel Financial
Missouri
$1.64M +$172K +5,035 +10%
Nomura Holdings
42
Nomura Holdings
Japan
$1.58M +$1.78M +52,000 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$1.54M +$281K +8,208 +19%
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$1.37M +$1.5M +43,898 +3,372%
JMPWA
45
JP Morgan Private Wealth Advisors
California
$1.29M +$133K +3,892 +10%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.29M +$12.5K +366 +0.9%
TA
47
Teton Advisors
New York
$1.21M – – –
Bank of America
48
Bank of America
North Carolina
$1.18M +$636K +18,579 +91%
DM
49
Diker Management
New York
$1.09M +$35.3K +1,032 +3%
SFM
50
Systematic Financial Management
New Jersey
$1.08M -$64.2K -1,875 -5%
1
2
3 4 5

ANIK Hedge Fund Activity: Q1 2019 in Review

157 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2019, worth a combined $403M — down 6% from $429M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ANIK and 19 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 75 added.

The largest buyer was Ameriprise, adding an estimated $15M. The largest seller was First Manhattan, exiting entirely with an estimated $13.8M sold.

  • 157 institutional investors held Anika Therapeutics (ANIK) as of Q1 2019, down from 162 in Q4 2018.
  • Funds reported $403M of Anika Therapeutics stock for Q1 2019, down 6% quarter-over-quarter.
  • 19 funds opened new Anika Therapeutics positions in Q1 2019 and 22 closed out, a net change of -3 holders.
  • The largest Anika Therapeutics buyer in Q1 2019 was Ameriprise, an estimated $15M added.
  • The largest Anika Therapeutics seller in Q1 2019 was First Manhattan, an estimated $13.8M sold.

Based on aggregated 13F filings for Q1 2019.